Japan· JP-2123404D3028
ランジオロール塩酸塩
A landiolol product containing ランジオロール塩酸塩, registered in Japan by 小野薬品工業, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Landiolol is registered in 15 of 19 countries.
Countries holding a registration under ATC C07AB14 (landiolol), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 9 of them publish a price we can compare per daily dose
Landiolol · ATC C07AB14
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ランジオロール塩酸塩
- Manufacturer
- 小野薬品工業
- Country
- Japan (JP)
- ATC code
- C07AB14
- ATC class
- Landiolol
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Landiolol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRAPIBLOCAmomed Pharma GmbH, Vídeň
- NetherlandsLandiolol Hydrochloride Orpha-Devel 300 mg poeder voor oplossing voor infusieOrpha Devel Handels-und Vertriebs GmbH
- United StatesRAPIBLYKAOP Orphan Pharmaceuticals GmbH
- FranceRAPIBLOC 20 mg/2 ml, solution à diluer injectableAMOMED PHARMA (AUTRICHE)
- SwedenRapibloc 10 mg/ml Koncentrat till injektionsvätska, lösningAmomed Pharma GmbH
- IrelandRapibloc 300 mg powder for solution for infusionOrpha-Devel Handels und Vertriebs GmbH
- NorwayRaplocAmomed Pharma GmbH
- PolandRunrapiqAmomed Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Rapibloc
- Belgium · Runrapiq
- Bulgaria · Рапиблок
- Cyprus · Rapibloc
- Czechia · Rapibloc
- Germany · Rapibloc
- Denmark · Rapibloc
- Estonia · Raploc
- Spain · Rapibloc
- Finland · Rapibloc
- France · Rapibloc
- Greece · Rapibloc
- Croatia · Rapibloc
- Hungary · Rapibloc
- Ireland · Rapibloc
- Italy · Landiobloc
- Lithuania · Raploc
- Latvia · Raploc
- Netherlands · Landiolol Hydrochloride Orpha-Devel, Rapibloc
- Norway · Raploc
- Poland · Runrapiq
- Portugal · Rapibloc
- Romania · Rapibloc
- Sweden · Rapibloc
- Slovenia · Rapibloc
- Slovakia · Rapibloc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2179fc17-eda2-4192-bf06-69ab77c805f0 GET /v1/drugs/2179fc17-eda2-4192-bf06-69ab77c805f0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "150mg1瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2123404D3028",
"category": "注射薬",
"price_yen": 9057,
"generic_name": "ランジオロール塩酸塩",
"product_name_jp": null,
"therapeutic_class": "2123",
"transitional_expiry": null
}See everything about landiolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.